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Histone acetylation as a new 
mechanism for bilirubin-induced 
encephalopathy in the Gunn rat
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Cristina Bottin3, Andrea Dardis2, Fabrizio Zanconati3, Claudio Tiribelli  1 & Silvia Gazzin1
Bilirubin neurotoxicity has been studied for decades and has been shown to affect various mechanisms 
via significant modulation of gene expression. This suggests that vital regulatory mechanisms of 
gene expression, such as epigenetic mechanisms, could play a role in bilirubin neurotoxicity. Histone 
acetylation has recently received attention in the CNS due to its role in gene modulation for numerous 
biological processes, such as synaptic plasticity, learning, memory, development and differentiation. 
Aberrant epigenetic regulation of gene expression in psychiatric and neurodegenerative disorders has 
also been described. In this work, we followed the levels of histone 3 lysine 14 acetylation (H3K14Ac) 
in the cerebellum (Cll) of the developing (2, 9, 17 days after the birth) and adult Gunn rat, the natural 
model for neonatal hyperbilirubinemia and kernicterus. We observed an age-specific alteration of 
the H3K14Ac in the hyperbilirubinemic animals. The GeneOntology analysis of the H3K14Ac linked 
chromatin revealed that almost 45% of H3K14Ac ChiP-Seq TSS-promoter genes were involved in 
CNS development including maturation and differentiation, morphogenesis, dendritogenesis, 
and migration. These data suggest that the hallmark Cll hypoplasia in the Gunn rat occurs also via 
epigenetically controlled mechanisms during the maturation of this brain structure, unraveling a novel 
aspect of the bilirubin-induced neurotoxicity.
Bilirubin toxicity to the CNS has been extensively studied for decades and has been shown to be linked to the 
activation of multiple complex signal cascades, and affects potential toxic/adaptation mechanisms in the brain 
through gene expression modulation. Examples include oxidative stress and the antioxidant response, excitotox-
icity, inflammation, intracellular trafficking, protein degradation, apoptosis, as well as bilirubin transport and 
bilirubin oxidization (reviewed in1).
Epigenetic processes, such as histone acetylation and DNA methylation, regulate the expression of genes 
through modifications of DNA structure and accessibility. These regulatory mechanisms often contribute to 
the onset and progression of human neurological disorders, and are altered by toxic compounds (e.g.: cocaine, 
alcohol)2–8. Indeed, histone acetylation is considered an integral part of brain development and differentiation, 
synaptic plasticity, learning, memory, and neuron maintenance and survival9–12. Notably, it is reported that tem-
poral changes in gene expression by acetylation/deacetylation of gene promoters induce persistent changes in the 
cell (e.g. cell fate), changes in the neurological behaviour8, as well induction of excitotoxicity, calcium overload, 
oxidative stress, inflammation and apoptosis13, with the last five described mechanisms in hyperbilirubinemic 
animals and humans. This suggests the possibility of a link between the hyperbilirubinemic phenotype and the 
epigenetic. On this basis, we decided to investigate the effect of hyperbilirubinemia on the epigenetic control of 
the Cll hypoplasia.
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Results
Serum bilirubin and cerebellar development. To evaluate the possible correlation between serum bili-
rubin and the levels of H3K14Ac, we quantified total and free bilirubin in the blood, and the Cll weight in hyper-
bilirubinemic pups (jj) and normobilirubinemic littermates (control: ctrl) from 2 days after birth (P2) until the 
adult age. At every post-natal age, the total serum bilirubin (TSB, Fig. 1A) was statistically higher in jj animals 
compared to ctrl (Σ8.5 lifelong, one-way ANOVA: p ≤ 0.0001, followed by Tukey post-test, p ≤ 0.001). At P2, the 
TSB was about of 190 µM, peaking at P17 (Σ256 µM), and stabilizing in the adulthood (Σ126 µM), (ever signifi-
cantly higher than in ctrl, one-way ANOVA: p ≤ 0.0001, followed by Tukey post-test, p ≤ 0.001).
Free bilirubin is the moiety able to cross the blood-brain interfaces leading to neurological damage. In the 
absence of a reliable method for a direct quantification in the rat, free bilirubin was calculated as previously 
Figure 1. Total Serum Bilirubin (TSB), calculated free bilirubin (cBf) in the blood, cerebellar weight, and 
Western blot analysis of the level of histone 3 acetylation (H3K14Ac) P: post-natal age in days, Adult: more than 
1-year-old. Black bars jj rats, White bars: ctrls. (A) TSB (µM); (B) cBf (nM), (C) Cll weight (mg/animal). Results 
are expressed as mean ± S.D. of 6–15 animals each group and post-natal age. One way ANOVA followed by 
Tukey post-test: ***p < 0.001. (D) H3K14Ac levels in the Cll of jj animals vs. ctrl. Results are as mean ± S.D. of 
3–6 animals each group and post-natal age. Unpaired t-test with Welch correction, *p < 0.05 vs. age matched 
ctrl.
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described14. Differently from TSB, the calculated Bf (cBf, Fig. 1B) level in jj pups dropped during development 
(P2 Σ150 nM, P9 Σ120 nM, P17 Σ35 nM, ever significantly higher than in ctrl, one-way ANOVA: p ≤ 0.0001, 
followed by Tukey post-test, p ≤ 0.001), felling to the levels not statistically different from those in ctrl in the adult 
age (adult jj Σ7 nM; One way ANOVA, followed by Tukey post-test, p > 0.05).
Cll weight (Fig. 1C) was similar in jj and ctrl littermates up to P9, becoming significantly different at P17 
(Σ30% weight loss vs. age-matched ctrl, one way ANOVA followed by Tukey post-test: p < 0.001), and increasing 
later on (Adult: Σ40%, one way ANOVA followed by Tukey post-test: p < 0.001).
Western blot analysis of global acetylation of histone H3K14. The follow the level of H3K14Ac 
in the developing cerebellum of jj and controls rats by Western blot, we used the 07-353 anti-H3K13Ac anti-
body. At P2, no significant difference was observed in the level of H3K14Ac in the Cll of jj animals compared to 
age-matched ctrl (Fig. 1D) (unpaired t-test with Welch correction, p = 0.2687). The level of H3K14Ac in jj was 
significantly increased (1.65 ± 0.54 fold, unpaired t-test with Welch correction, p < 0.0222) at P9 and significantly 
decreased at P17 (0.67 ± 0.18 fold, unpaired t-test with Welch correction, p < 0.0187). In the adults there was no 
difference in the level of H3K14Ac between jj and ctrl (unpaired t-test with Welch correction, p = 0.4508).
ChIP-Seq analysis. To link the effect of hyperbilirubinemia on H3K14Ac with the genes controlled by this 
epigenetic mechanism, the 07–353 anti-H3K13Ac antibody used for Western blot analysis was also used to per-
form chromatin immunoprecipitation, followed by DNA sequencing (ChIP-Seq – full result available on GEO 
repository # GSE109145). After removal of duplicate DNA fragments and DNA fragments present in both jj and 
ctrl (physiological genes), 1884 unique DNA sequences were identified. Since variations in the level of histone 
acetylation in the promoter region positively correlate with gene transcription9,15, we focused on peaks identified 
by ChIP-Seq on the promoter regions (Table 1: 255 genes). As shown in Fig. 2, the functional annotation analysis 
of the corresponding genes16–18 revealed an enrichment for genes involved in CNS development (Σ45%), metab-
olism & homeostasis (Σ31%), signalling (Σ13%), response to stimuli & communication (Σ5%), transport (Σ5%), 
and binding (Σ2%).
Morphological features of the Gunn rat Cll. Since our results strongly suggested an impact of biliru-
bin on the genetic program of CNS maturation, we systematically followed the histological development of the 
cerebellum of jj rats in the attempt to interpret the genetic results. No morphological alterations between jj and 
ctrl were obvious at P2 (Fig. 3A,B). In both jj and ctrl animals, Purkinje cells were organized in 3–5 layers, with 
a round/oval shape and a reticulated cytoplasm (Fig. 3B). At P9, in spite of a conserved architecture, signs of 
cellular sufferance/death, microgliosis, extracellular matrix abnormalities and edema were evident in jj pups. 
PCs in ctrl displayed a clear definition of the plasma-membrane, cytoplasm, and nuclear areas, and a round/drop 
shape, and were organized in 3/1 layers. On the contrary, in jj pups, PCs were largely present in 4/2 layers, with 
an undefined, irregular shape. At P17, microgliosis and signs of cellular sufferance were still present in jj rats. PCs 
in ctrl were well differentiated, with a drop shape, and almost completely organized in a single layer, diffusely in 
2/1 layers and still presenting the altered morphology described at P9 in jj. In the adult animal, the effect of Cll 
hypoplasia was well appreciable, with a less developed structure characterized by large spaces between the folia 
(Fig. 3A). Microgliosis was reduced but still present. No PC’s neurites were visible in jj rats, where PCs appeared 
atrophic and apoptotic (Fig. 3B).
RTqPCR analysis of selected genes. Due to the surprising percentage of enrichment for genes involved 
in CNS development, we decided to confirm and quantify the epigenetic control of a selected panel of genes, by 
assessing their expression by RTqPCR (selected genes are those in red in Fig. 2B, in which their biological func-
tions based on the Gene Ontology analysis are indicated. RTqPCR results are in Fig. 4). Ptk2 (protein tyrosine 
kinase 2 beta, considered a key gene in neurite outgrowth and elongation, synapses formation, and actin reorgan-
ization19), was significantly down-regulated in P2 jj pups (Σ2 fold vs. age-matched ctrl, unpaired t-test with Welch 
correction, p < 0.047), normalizing thereafter. Mag (myelin-associated glycoprotein), barely detectable immedi-
ately after birth, was highly expressed in ctrl and Σ2.5 fold down-regulated in jj pups at P9 (unpaired t-test with 
Welch correction, p < 0.0402), reversing to a Σ1.2 fold up-regulation at P17 (unpaired t-test with Welch correc-
tion, p < 0.0306). Icam1 (intracellular adhesion molecule 1, expressed mainly by the endothelial cells forming the 
blood-brain barrier, involved in cell adhesion, leucocytes20 and monocytes extravasation21, and morphogenesis) 
was up-regulated 1.6 fold in P17 jj rats (unpaired t-test with Welch correction, p < 0.0416). Similarly, we observed 
a Σ2.2 fold increase (unpaired t-test with Welch correction, p < 0.0315) of Chmp1a (charged multi-vesicular 
body protein 1a, regulating the neural progenitor cell proliferation22). In adult jj Cll, Col4a3 (collagenase 4a3, 
the major structural component of the basal membrane, involved in the extracellular matrix remodeling23, pro-
viding the functional compartmentalization of the brain by clustering of growth factors, neurotransmitters/ions 
receptors, as well contributing to migration and differentiation24), Casp6 (caspase 6 - proliferation and morpho-
genesis – Fig. 2B), and Arghap4 (Rho GTPase-activating protein, inhibiting the cell motility and axon outgrowth 
via regulating the cytoskeleton dynamics25) were upregulated Σ2.5fold (unpaired t-test with Welch correction, 
p < 0.00547), Σ1.9fold (unpaired t-test with Welch correction, p < 0.0287) and Σ1.6 fold (unpaired t-test with 
Welch correction, p < 0.0142) respectively. No modulation of Anxa2 (annexin2), Agrn (Agrin), and Tubb2b 
(Tubulin2b) was detected at any post-natal age in jj rats (data not shown). Il6 (intron region segment resulting 
from ChIP-Seq analysis) was also investigated. In ctrl animals the Il6 level rapidly decreases from P2 to P9, sta-
bilizing thereafter. In jj pups, a significant down-regulation of Il6 was present immediately after birth compared 
to ctrl animals (Σ2.9fold, unpaired t-test with Welch correction, p < 0.0315), while a 1.65 fold up-regulation was 
noticed at P9 (unpaired t-test with Welch correction, p < 0.0248), normalizing later on.
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Gene Name Gene Description Nearest Refseq Gene Type
Abcc10 ATP-binding cassette, subfamily C (CFTR/MRP), member 10 NM_001108201 protein-coding
Acot13 acyl-CoA thioesterase 13 NM_001106111 protein-coding
Acp1 acid phosphatase 1, soluble NM_021262 protein-coding
Acpt acid phosphatase, testicular NM_001107510 protein-coding
Actc1 actin, alpha, cardiac muscle 1 NM_019183 protein-coding
Adra2b adrenoceptor alpha 2B NM_138505 protein-coding
Agrn agrin NM_175754 protein-coding
Ahrr aryl-hydrocarbon receptor repressor NM_001024285 protein-coding
Aldh3a2 aldehyde dehydrogenase 3 family, member A2 NM_031731 protein-coding
Alg11 ALG11, alpha-1,2-mannosyltransferase NM_001108401 protein-coding
Alg8 ALG8, alpha-1,3-glucosyltransferase NM_001034127 protein-coding
Amdhd1 amidohydrolase domain containing 1 NM_001191781 protein-coding
Anxa2 annexin A2 NM_019905 protein-coding
Arfgap2 ADP-ribosylation factor GTPase activating protein 2 NM_001033707 protein-coding
Arhgap4 Rho GTPase activating protein 4 NM_144740 protein-coding
Asl argininosuccinate lyase NM_021577 protein-coding
Atp6v0e1 ATPase, H+ transporting, lysosomal, V0 subunit e1 NM_053578 protein-coding
Atraid all-trans retinoic acid-induced differentiation factor NM_001127526 protein-coding
B3galt4 UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4 NM_133553 protein-coding
Bbs2 Bardet-Biedl syndrome 2 NM_053618 protein-coding
Bbs5 Bardet-Biedl syndrome 5 NM_001108583 protein-coding
Bin2 bridging integrator 2 NM_001012223 protein-coding
Bphl biphenyl hydrolase-like (serine hydrolase) NM_001037206 protein-coding
Brd9 bromodomain containing 9 NM_001107453 protein-coding
Cacng8 calcium channel, voltage-dependent, gamma subunit 8 NM_080696 protein-coding
Cap1 CAP, adenylate cyclase-associated protein 1 (yeast) NM_022383 protein-coding
Casp6 caspase 6 NM_031775 protein-coding
Cblc Cbl proto-oncogene C, E3 ubiquitin protein ligase NM_001034920 protein-coding
Cct6a chaperonin containing Tcp1, subunit 6 A (zeta 1) NM_001033684 protein-coding
Cdc20 cell division cycle 20 NM_171993 protein-coding
Cers1 ceramide synthase 1 NM_001044230 protein-coding
Chad chondroadherin NM_019164 protein-coding
Chmp1a charged multivesicular body protein 1 A NM_001083313 protein-coding
Chrnb1 cholinergic receptor, nicotinic, beta 1 (muscle) NM_012528 protein-coding
Ciapin1 cytokine induced apoptosis inhibitor 1 NM_001007689 protein-coding
Cidea cell death-inducing DFFA-like effector a NM_001170467 protein-coding
Clpsl2 colipase-like 2 NM_001135002 protein-coding
Cnksr1 connector enhancer of kinase suppressor of Ras 1 NM_001039011 protein-coding
Col4a3 collagen, type IV, alpha 3 NM_001135759 protein-coding
Col7a1 collagen, type VII, alpha 1 NM_001106858 protein-coding
Cpne6 copine VI (neuronal) NM_001191113 protein-coding
Cpsf3l cleavage and polyadenylation specific factor 3-like NM_001033892 protein-coding
Cpsf4 cleavage and polyadenylation specific factor 4 NM_001012351 protein-coding
Crcp CGRP receptor component NM_053670 protein-coding
Cth cystathionine gamma-lyase NM_017074 protein-coding
Ctr9 CTR9 homolog, Paf1/RNA polymerase II complex component NM_001100661 protein-coding
Cyb5r1 cytochrome b5 reductase 1 NM_001013126 protein-coding
Cyba cytochrome b-245, alpha polypeptide NM_024160 protein-coding
Ddb1 damage-specific DNA binding protein 1, 127 kDa NM_171995 protein-coding
Ddb2 damage specific DNA binding protein 2 NM_001271346 protein-coding
Ddias DNA damage-induced apoptosis suppressor NM_001126294 protein-coding
Ddit4l2 DNA-damage-inducible transcript 4-like 2 NM_080399 protein-coding
Ddx55 DEAD (Asp-Glu-Ala-Asp) box polypeptide 55 NM_001271326 protein-coding
Ddx56 DEAD (Asp-Glu-Ala-Asp) box helicase 56 NM_001004211 protein-coding
Dhdds dehydrodolichyl diphosphate synthase subunit NM_001011978 protein-coding
Continued
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Gene Name Gene Description Nearest Refseq Gene Type
Dmrtc2 DMRT-like family C2 NM_001109140 protein-coding
Dnaja1 DnaJ (Hsp40) homolog, subfamily A, member 1 NM_022934 protein-coding
Eif3e eukaryotic translation initiation factor 3, subunit E NM_001011990 protein-coding
Emc3 ER membrane protein complex subunit 3 NM_001008355 protein-coding
Emd emerin NM_012948 protein-coding
Entpd6 ectonucleoside triphosphate diphosphohydrolase 6 NM_053498 protein-coding
Eny2 enhancer of yellow 2 homolog (Drosophila) NM_001130580 protein-coding
Ephx2 epoxide hydrolase 2, cytoplasmic NM_022936 protein-coding
Fam151a family with sequence similarity 151, member A NM_001005558 protein-coding
Fam178b family with sequence similarity 178, member B NM_001122653 protein-coding
Fam192a family with sequence similarity 192, member A NM_001014014 protein-coding
Fanca Fanconi anemia, complementation group A NM_001108455 protein-coding
Fbxo44 F-box protein 44 NM_001191576 protein-coding
Fdxr ferredoxin reductase NM_024153 protein-coding
Fgfr1op2 FGFR1 oncogene partner 2 NM_201421 protein-coding
Fkbp6 FK506 binding protein 6 NM_001105922 protein-coding
Foxm1 forkhead box M1 NM_031633 protein-coding
Fyco1 FYVE and coiled-coil domain containing 1 NM_001106870 protein-coding
Gamt guanidinoacetate N-methyltransferase NM_012793 protein-coding
Gdf1 growth differentiation factor 1 NM_001044240 protein-coding
Gja4 gap junction protein, alpha 4 NM_021654 protein-coding
Gjd4 gap junction protein, delta 4 NM_001100487 protein-coding
Gna15 guanine nucleotide binding protein, alpha 15 NM_053542 protein-coding
Gng5 guanine nucleotide binding protein (G protein), gamma 5 NM_024377 protein-coding
Gnmt glycine N-methyltransferase NM_017084 protein-coding
Gnpat glyceronephosphate O-acyltransferase NM_053410 protein-coding
Gosr2 golgi SNAP receptor complex member 2 NM_031685 protein-coding
Gpalpp1 GPALPP motifs containing 1 NM_001024875 protein-coding
Gtf2e1 general transcription factor IIE, polypeptide 1, alpha NM_001100556 protein-coding
Gtsf1 gametocyte specific factor 1 NM_001079707 protein-coding
Gzf1 GDNF-inducible zinc finger protein 1 NM_001107788 protein-coding
Hcfc1r1 host cell factor C1 regulator 1 (XPO1-dependent) NM_001100492 protein-coding
Higd2a HIG1 hypoxia inducible domain family, member 2 A NM_001106102 protein-coding
Hist3h2a histone cluster 3, H2a NM_021840 protein-coding
Hist3h2bb histone cluster 3, H2bb NM_001109641 protein-coding
Hoxc8 homeobox C8 NM_001177326 protein-coding
Hoxd10 homeo box D10 NM_001107094 protein-coding
Hrg histidine-rich glycoprotein NM_133428 protein-coding
Icam1 intercellular adhesion molecule 1 NM_012967 protein-coding
Idua iduronidase, alpha-L- NM_001172084 protein-coding
Ift122 intraflagellar transport 122 NM_001009416 protein-coding
Ikzf5 IKAROS family zinc finger 5 NM_001107555 protein-coding
Il17rb interleukin 17 receptor B NM_001107290 protein-coding
Itga4 integrin, alpha 4 NM_001107737 protein-coding
Jagn1 jagunal homolog 1 NM_001044272 protein-coding
Jtb jumping translocation breakpoint NM_019213 protein-coding
Kb15 type II keratin Kb15 NM_001008825 protein-coding
Kcne5 potassium channel, voltage-gated Isk-related subfamily E regulatory beta subunit 5 NM_001101003 protein-coding
Kdelr1 KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1 NM_001017385 protein-coding
Kiaa0895l hypothetical protein LOC688736 NM_001044292 protein-coding
Kif11 kinesin family member 11 NM_001169112 protein-coding
Kif18b kinesin family member 18B NM_001039019 protein-coding
Klrd1 killer cell lectin-like receptor, subfamily D, member 1 NM_012745 protein-coding
Krt33b keratin 33B NM_001008819 protein-coding
Lars2 leucyl-tRNA synthetase 2, mitochondrial NM_001108787 protein-coding
Continued
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Gene Name Gene Description Nearest Refseq Gene Type
Leng1 leukocyte receptor cluster (LRC) member 1 NM_001106218 protein-coding
Lhx1 LIM homeobox 1 NM_145880 protein-coding
LOC100912214 uncharacterized LOC100912214 NR_131101 ncRNA
LOC103689982 lysophospholipid acyltransferase 7 NM_001313940 protein-coding
LOC288913 similar to LEYDIG CELL TUMOR 10 KD PROTEIN NM_198728 protein-coding
LOC498154 hypothetical protein LOC498154 NM_001025033 protein-coding
LOC688925 similar to Glutathione S-transferase alpha-4 NM_001270386 protein-coding
Lrrc14 leucine rich repeat containing 14 NM_001024354 protein-coding
Lrrc27 leucine rich repeat containing 27 NM_001113789 protein-coding
Lrrc36 leucine rich repeat containing 36 NM_001004088 protein-coding
Lrrc51 leucine rich repeat containing 51 NM_001106284 protein-coding
Lypd3 Ly6/Plaur domain containing 3 NM_021759 protein-coding
Lzic leucine zipper and CTNNBIP1 domain containing NM_001013241 protein-coding
Lztfl1 leucine zipper transcription factor-like 1 NM_001024266 protein-coding
Maf1 MAF1 homolog, negative regulator of RNA polymerase III NM_001014085 protein-coding
Mag myelin-associated glycoprotein NM_017190 protein-coding
Mal mal, T-cell differentiation protein NM_012798 protein-coding
Mboat7 membrane bound O-acyltransferase domain containing 7 NM_001134978 protein-coding
Mcemp1 mast cell-expressed membrane protein 1 NM_001134602 protein-coding
Mea1 male-enhanced antigen 1 NM_001044286 protein-coding
Med11 mediator complex subunit 11 NM_001105799 protein-coding
Mir137 microRNA 137 NR_031883 ncRNA
Mir207 microRNA 207 NR_032107 ncRNA
Mir338 microRNA 338 NR_031783 ncRNA
Mir3562 microRNA 3562 NR_037344 ncRNA
Misp mitotic spindle positioning NM_001109284 protein-coding
Mrpl43 mitochondrial ribosomal protein L43 NM_001107598 protein-coding
Mrps18b mitochondrial ribosomal protein S18B NM_212534 protein-coding
Mrps25 mitochondrial ribosomal protein S25 NM_001025408 protein-coding
Mt2A metallothionein 2A NM_001137564 protein-coding
Mt3 metallothionein 3 NM_053968 protein-coding
Mterf3 mitochondrial transcription termination factor 3 NM_199387 protein-coding
Mtf1 metal-regulatory transcription factor 1 NM_001108677 protein-coding
Mtf2 metal response element binding transcription factor 2 NM_001100898 protein-coding
Myeov2 myeloma overexpressed 2 NM_001109044 protein-coding
Naa38 N(alpha)-acetyltransferase 38, NatC auxiliary subunit NM_001105794 protein-coding
Ncbp1 nuclear cap binding protein subunit 1 NM_001014785 protein-coding
Ncoa4 nuclear receptor coactivator 4 NM_001034007 protein-coding
Ndor1 NADPH dependent diflavin oxidoreductase 1 NM_001107818 protein-coding
Ndufb8 NADH dehydrogenase (ubiquinone) 1 beta subcomplex 8 NM_001106360 protein-coding
Ndufs5 NADH dehydrogenase (ubiquinone) Fe-S protein 5 NM_001030052 protein-coding
Ndufv3 NADH dehydrogenase (ubiquinone) flavoprotein 3 NM_022607 protein-coding
Nipsnap1 nipsnap homolog 1 (C. elegans) NM_001100730 protein-coding
Nme3 NME/NM23 nucleoside diphosphate kinase 3 NM_053507 protein-coding
Nmi N-myc (and STAT) interactor NM_001034148 protein-coding
Nmu neuromedin U NM_022239 protein-coding
Nob1 NIN1/RPN12 binding protein 1 homolog NM_199086 protein-coding
Nolc1 nucleolar and coiled-body phosphoprotein 1 NM_022869 protein-coding
Nr2c2ap nuclear receptor 2C2-associated protein NM_001047104 protein-coding
Nsl1 NSL1, MIS12 kinetochore complex component NM_001109083 protein-coding
Ntpcr nucleoside-triphosphatase, cancer-related NM_001134573 protein-coding
Ntsr1 neurotensin receptor 1 NM_001108967 protein-coding
Nubp2 nucleotide binding protein 2 NM_001011891 protein-coding
Nudt2 nudix (nucleoside diphosphate linked moiety X)-type motif 2 NM_207596 protein-coding
Olr437 olfactory receptor 437 NM_001109347 protein-coding
Olr760 olfactory receptor 760 NM_001001069 protein-coding
Continued
www.nature.com/scientificreports/
7Scientific REpoRTS |  (2018) 8:13690  | DOI:10.1038/s41598-018-32106-w
Gene Name Gene Description Nearest Refseq Gene Type
Ovca2 ovarian tumor suppressor candidate 2 NM_001109036 protein-coding
Pcdha3 protocadherin alpha 3 NM_053941 protein-coding
Pctp phosphatidylcholine transfer protein NM_017225 protein-coding
Pex1 peroxisomal biogenesis factor 1 NM_001109220 protein-coding
Phlda2 pleckstrin homology-like domain, family A, member 2 NM_001100521 protein-coding
Phldb3 pleckstrin homology-like domain, family B, member 3 NM_001191622 protein-coding
Pigp phosphatidylinositol glycan anchor biosynthesis, class P NM_001099758 protein-coding
Plcxd2 phosphatidylinositol-specific phospholipase C, X domain containing 2 NM_001134481 protein-coding
Plp2 proteolipid protein 2 (colonic epithelium-enriched) NM_207601 protein-coding
Pmf1 polyamine-modulated factor 1 NM_001191568 protein-coding
Pnldc1 poly(A)-specific ribonuclease (PARN)-like domain containing 1 NM_001025724 protein-coding
Polr3d polymerase (RNA) III (DNA directed) polypeptide D NM_001031653 protein-coding
Pou6f1 POU class 6 homeobox 1 NM_001105746 protein-coding
Ppp1r11 protein phosphatase 1, regulatory (inhibitor) subunit 11 NM_212542 protein-coding
Ppt2 palmitoyl-protein thioesterase 2 NM_019367 protein-coding
Psmg4 proteasome (prosome, macropain) assembly chaperone 4 NM_001109543 protein-coding
Ptcd1 pentatricopeptide repeat domain 1 NM_001109665 protein-coding
Ptk2b protein tyrosine kinase 2 beta NM_017318 protein-coding
Qk quaking NM_001115021 protein-coding
Rab3gap2 RAB3 GTPase activating protein subunit 2 NM_001008294 protein-coding
Rab5c RAB5C, member RAS oncogene family NM_001105840 protein-coding
Rad51ap1 RAD51 associated protein 1 NM_001079711 protein-coding
Ranbp10 RAN binding protein 10 NM_001135875 protein-coding
Rec8 REC8 meiotic recombination protein NM_001011916 protein-coding
Rfc2 replication factor C (activator 1) 2 NM_053786 protein-coding
RGD1307443 similar to mKIAA0319 protein NM_001197023 protein-coding
RGD1309188 similar to hypothetical protein BC011833 NM_001108129 protein-coding
RGD1309676 similar to RIKEN cDNA 5730469M10 NM_001014140 protein-coding
RGD1311703 similar to sid2057p NM_001013898 protein-coding
RGD1359334 similar to hypothetical protein FLJ20519 NM_001007638 protein-coding
RGD1559909 RGD1559909 NM_001108678 protein-coding
RGD1560608 similar to novel protein NM_001109280 protein-coding
RGD1562683 RGD1562683 NM_001108314 protein-coding
RGD1563714 RGD1563714 NM_001126297 protein-coding
RGD1564036 similar to RIKEN cDNA 3010026O09 NM_001109030 protein-coding
Ribc2 RIB43 A domain with coiled-coils 2 NM_001013949 protein-coding
Rnf40 ring finger protein 40, E3 ubiquitin protein ligase NM_153471 protein-coding
Rph3a rabphilin 3A NM_133518 protein-coding
Rpl27 ribosomal protein L27 NM_022514 protein-coding
Rpl27a ribosomal protein L27a NM_001106290 protein-coding
Rspry1 ring finger and SPRY domain containing 1 NM_001100945 protein-coding
Rxfp3 relaxin/insulin-like family peptide receptor 3 NM_001008310 protein-coding
Sart3 squamous cell carcinoma antigen recognized by T-cells 3 NM_001107156 protein-coding
Scly selenocysteine lyase NM_001007755 protein-coding
Sert1 Sertoli cell protein 1 NR_130708 ncRNA
Sfxn3 sideroflexin 3 NM_022948 protein-coding
Skap2 src kinase associated phosphoprotein 2 NM_130413 protein-coding
Slc19a2 solute carrier family 19 (thiamine transporter), member 2 NM_001030024 protein-coding
Slc25a54 solute carrier family 25, member 54 NM_001109640 protein-coding
Slc43a3 solute carrier family 43, member 3 NM_001107743 protein-coding
Slc5a6 solute carrier family 5 (sodium/multivitamin and iodide cotransporter), member 6 NM_130746 protein-coding
Slc6a20 solute carrier family 6 (proline IMINO transporter), member 20 NM_133296 protein-coding
Slc6a3 solute carrier family 6 (neurotransmitter transporter), member 3 NM_012694 protein-coding
Snrnp35 small nuclear ribonucleoprotein 35 (U11/U12) NM_001014127 protein-coding
Snrpb2 small nuclear ribonucleoprotein polypeptide B” NM_001108592 protein-coding
Continued
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Discussion
Cll hypoplasia is a hallmark of hyperbilirubinemia in rodents26–29, and cerebellar involvement with morphological 
and behavioral abnormalities has also been reported in severely hyperbilirubinemic neonates30–32. Inflammation 
and oxidative stress are considered the major mechanisms of bilirubin neurotoxicity, whereas the impact of 
hyperbilirubinaemia on CNS development has been only marginally envisaged, and evaluated mostly by in vitro 
experiments33,34.
Unexpectedly, the known inflammatory or oxidant effectors of bilirubin neurotoxicity have been not identified 
in our data (ChIP-Seq, followed by Gene Ontology analysis), revealing that 45% of genes displaying a Histone 
3 lysine 14 acetylation are related to CNS development. Indeed, only 3 genes among all the 255 identified TSS- 
Promoter sequences have been previously reported in the literature for their association with hyperbilirubinemia, 
namely myelin28,31,32,34, tubulin35, and Icam136.
The down-regulation of Mag has been reported in in vitro studies, in agreement with the defective myelina-
tion observed both in bilirubin neurotoxicity models28,34 and neonates32. Mag down-regulation is also a known 
consequence of bilirubin-induced perturbation of the oligodendrocytes maturation. A possible additional link 
between what has been previously described and the present results is the fact that histone acetylation is a known 
mechanism controlling oligodendrocyte differentiation and myelin production, both in physiological CNS devel-
opment and in repair processes after demyelination6,10.
Our data are in agreement with the literature also in relation to Il6, whose intron sequence was identified by 
ChIP-Seq analysis. Il6 is a well-known effector of bilirubin neurotoxicity and possibly linked with the reported 
defective myelination. In fact, apart from the possible inflammatory activity, Il6 is involved in oligodendrogene-
sis37,38, a process active up to P45 in rodents and 2 years in humans39, and reactivated in pathological conditions. 
During reactivation, injured neurons and oligodendrocytes may reactivate myelin synthesis by overexpressing Il6 
and its receptor (Il6r/CD126), restoring normal behavior in injured animals10,40.
Gene Name Gene Description Nearest Refseq Gene Type
Spag7 sperm associated antigen 7 NM_001107016 protein-coding
Spata33 spermatogenesis associated 33 NM_001106195 protein-coding
Spata5 spermatogenesis associated 5 NM_001108549 protein-coding
Spic Spi-C transcription factor (Spi-1/PU.1 related) NM_001108080 protein-coding
Stam signal transducing adaptor molecule (SH3 domain and ITAM motif) 1 NM_001109121 protein-coding
Stk19 serine/threonine kinase 19 NM_001013197 protein-coding
Susd3 sushi domain containing 3 NM_001107341 protein-coding
Tada3 transcriptional adaptor 3 NM_001025734 protein-coding
Taf6l TAF6-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor NM_001107575 protein-coding
Tax1bp3 Tax1 (human T-cell leukemia virus type I) binding protein 3 NM_001025419 protein-coding
Tbc1d25 TBC1 domain family, member 25 NM_001106955 protein-coding
Tbcb tubulin folding cofactor B NM_001040180 protein-coding
Them4 thioesterase superfamily member 4 NM_001025017 protein-coding
Tmem109 transmembrane protein 109 NM_001007736 protein-coding
Tmem126a transmembrane protein 126 A NM_001011557 protein-coding
Tnxa-ps1 tenascin XA, pseudogene 1 NR_024118 pseudo
Trappc1 trafficking protein particle complex 1 NM_001039378 protein-coding
Trim23 tripartite motif-containing 23 NM_001100637 protein-coding
Trip13 thyroid hormone receptor interactor 13 NM_001011930 protein-coding
Trip4 thyroid hormone receptor interactor 4 NM_001134981 protein-coding
Trmt112 tRNA methyltransferase 11-2 homolog (S. cerevisiae) NM_001106330 protein-coding
Tsc2 tuberous sclerosis 2 NM_012680 protein-coding
Tstd2 thiosulfate sulfurtransferase (rhodanese)-like domain containing 2 NM_001108663 protein-coding
Ttc3 tetratricopeptide repeat domain 3 NM_001108315 protein-coding
Tuba3a tubulin, alpha 3A NM_001040008 protein-coding
Tuba4a tubulin, alpha 4A NM_001007004 protein-coding
Tubb2b tubulin, beta 2B class IIb NM_001013886 protein-coding
Ufsp2 UFM1-specific peptidase 2 NM_001014142 protein-coding
Vmp1 vacuole membrane protein 1 NM_138839 protein-coding
Vwa7 von Willebrand factor A domain containing 7 NM_212499 protein-coding
Zbtb26 zinc finger and BTB domain containing 26 NM_001107840 protein-coding
Zfp142 zinc finger protein 142 NM_001108225 protein-coding
Zfp597 zinc finger protein 597 NM_153732 protein-coding
Zscan21 zinc finger and SCAN domain containing 21 NM_001012021 protein-coding
Table 1. Full list of ChIP-Seq TSS-Promoter genes.
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Both Mag and Il6 present a fluctuating behavior, being significantly down-regulated in the early post-natal life, 
and reverting thereafter to the level of age-matched controls (Fig. 4). Notably, in our work, IL6 modulation (P9) 
precedes Mag increase (P17), supporting the inductor role of Il6 in myelination described in the literature10,40. 
The fluctuating expression of Il6 and Mag (firstly up-, then down regulated), is present also for H3K14Ac levels, 
increasing at P9, and reverting under the level of age-matched controls at P17, and normalizing in the adult age.
The regulation of the other genes is more difficult to be analyzed since they are very new in the bilirubin field 
and no data are provided by literature. While we still have to confirm the role of the various genes identified in 
this study through methods such as gene silencing in vitro, our work suggests that the epigenetic impairment 
of neurodevelopmental processes in hyperbilirubinemia may be a relevant mechanism of bilirubin neurotoxic-
ity. It is worth mentioning that Chmp1a, Arghap4, Casp6, Ptk2, Col4a3 are genes involved in key steps of brain 
development as proliferation, migration, morphogenesis, neurite outgrowth and elongation, synaptogenesis, 
extracellular matrix formation and compartmentalization, as well the pathological axonal degeneration and 
apoptosis observed19,22,25,41,42 in jj rats. By adding epigenetic dysregulation to the list of the mechanisms related 
to bilirubin-induced neuronal damage, we can confirm and expand the concept of a widespread toxic effect of 
the pigment on the CNS43, improving our understanding of the cellular and molecular mechanisms of bilirubin 
induced damage to CNS.
Materials and Methods
Animals. Gunn rats (Hds Blue:Gunn-UDPGTj, P2, 9, 17; P ± 1 day. Adult = more than 1 year old) were 
obtained from the SPF animal facility of CBM S.c.a.r.l. (AREA Science Park, Basovizza). Ages were selected 
based on previous evidence26,44. Animals were housed in a temperature-controlled environment (22 ± 2 °C), on 
a 12 hours light/dark schedule, and ad-libitum access to food and water. The study was approved by the animal 
care and use committee of the CBM Scarl and the competent Italian Ministry. All procedures were performed 
according to the Italian Law (decree 87-848) and European Community directive (86-606-ECC). Maximal effort 
to minimize the number of the animals used and their sufferance was done.
Figure 2. Biological function of the identified Chip-Seq chromatin sequences (A) GeneCodis analysis (on 
genes with peaks found in their TSS-promoter regions) for enriched biological functions. (B) List of the 94 (45% 
of the total found) genes enriched for functions related to the CNS development. In red, genes confirmed by 
RTqPCR. Hypergeometric p-value ever <0.00005, Corrected (FDR) Hypergeometric p-value < 0.05.
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TSB, cBf and Cerebellum weight quantification. Serum and Cll were collected as previously 
described26,45. In brief, blood samples were collected during the sacrifice (decapitation under urethane anaes-
thesia 1.0–1.2 g/kg IP) and centrifuged at 2000 rpm, 20 min RT. Total serum bilirubin (TSB) was quantified by 
the diazo reaction, as previously described26. Free bilirubin was calculated (cBf) by applying the formula and the 
albumin-bilirubin dissociation constants for Gunn pups detailed in literature14. Cerebellum was dissected imme-
diately after the sacrifice, and the weight recorded by a precision balance.
Western blot analysis of the levels of H3K14Ac. Western blot was performed as previously 
described44,45. In brief, Cll were mechanically homogenized by glass-glass Dounce (in 0.25 M sucrose, 40.2 mM 
KH2PO4, 9.8 mM K2HPO4, 1 mM EDTA, 0.1 mM DTT, pH 7.4), and total protein concentration quantified by the 
Bicinchoninic Acid Protein Assay following the supplier instruction (B-9643 and C2284, Sigma, Missouri, USA). 
25 μg of Cll whole extract proteins were denatured (10% of β-mercaptoethanol -Sigma Chemical, St. Louis, MO, 
USA, plus 5 min boiling), separated by 12% SDS-PAGE by electrophoresis in a Hoefer SE 250 System (Amersham 
Figure 3. Histological finding (A) Full Cll images (scale bar 400 µm) showing the normal development (ctrl, 
upper series of pictures) and the progression of the Cll hypoplasia in jj animals (lower series of pictures). (B) 
Details (scale bar 100 µm) of the major histological alterations in the developing Cll of jj rat vs. age matched ctrl. 
P: post-natal age in days, Adult: more than 1 year old. *Purkinje cells (PCs); >PC’s neurites; ∆ microgliosis; [] 
extracellular matrix alteration; → oedema. 2–3 animals each genotype/age have been used. Miniatures: Nissl 
stain. Larger pictures: Haematoxylin & Eosin.
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BioSciences, UK), and electro-transferred onto immune-blot PVDF membranes (0.2 μm; Whatman Schkleicher 
and Schuell, Dassel, Germany) at 100 V for 60 min (Bio-Rad Laboratories, Hercules, CA, USA). Efficiency of the 
transfer was assessed by lack of Coomassie blue coloration of the gel after blotting, and Ponceau staining of the 
PVDF membrane (both chemicals: Sigma, St. Louis, MO, USA). After blocking (1.5 hrs, RT in blocking solution: 
3% defatted milk in 0.2% Tween 20; 20 mM Tris-HCl pH 7.5; 500 mM NaCl), membranes were incubated O/N 
at 4 °C with the polyclonal anti-acetyl histone H3 (lys14) antibody (07-353, Merck Millipore, Temecula, CA, 
USA; final concentration 0.7 μg/mL). The day after, membranes were washed 3 × 5 min in blocking buffer, then 
incubated 2hrs with the secondary antibody anti-rabbit IgG peroxidase (Dako, Agilent Technologies, Santa Clara, 
CA, USA, final concentration 0.0625 μg/mL) in blocking solution. The signal was revealed by chemiluminescence 
(ECL-Plus Western blotting Detection Reagents, GE-Healthcare Bio-Science, Italy) and visualized on X-ray films 
(BioMax Light, Kodak Rochester, NY, USA). The results were normalized vs. the actin signal, visualized incubat-
ing the same membrane used for revealing the H3K14Ac with the anti-actin antibody A2066 (sigma- Chemical, 
St. Louis, MO, USA; final concentration 0.07 μg/mL, MW 42KDa). Bands intensity was quantified by the Scion 
Image software (GE Healthcare Europe GmbH, France).
ChIP-Seq analysis. The 07-353 anti-H3K13Ac antibody used for Western blot analysis was also used to 
perform chromatin immunoprecipitation, followed by DNA sequencing (ChIP-Seq – full result available on 
GEO repository # GSE109145). Chromatin immunoprecipitation (ChIP) was performed following the Magna 
ChIPTM G Tissue Kit (#17-20000, Merck Millipore, Temecula, CA, USA) procedure and applying the same 
Ab used in Western blot. Cll tissue (60 mg) was homogenized, DNA sheared (average size of 100–400 bp, by 
Sonopuls HD 3100, Bandelin, Germany, sonicator. Power 50%, 15″ × 18 cycles, 10″ pause between each cycle, 
on ice), cross-linked with 1% formaldehyde (5′, RT), and protein-DNA complexes immune-precipitated (5 μL, 
07-353 Ab, Merck Millipore, Temecula, CA, USA) by G magnetic beads on the magnetic rack (LSKMAGS08 Pure 
ProteomeTM Magnetic Stand, Merck Millipore, Temecula, CA, USA). Protein-DNA crosslink was reversed (pro-
teinase K, 62 °C, 2 h; plus 95° C × 10′), and DNA stored at −20 °C until use. As suggested by the manufacturer, the 
efficiency and specificity of the ChIP procedure were assessed by Western blot, and Real Time PCR (RTqPCR). 
Samples were quantified by Quant-iTTM PicoGreen® dsDNA Kits (Thermo Fisher Scientific, Waltham, MA, 
USA), according to manufacturer’s instruction.
Libraries were prepared by using the NEBNext® UltraTM II DNA Library Prep Kit from Illumina® (E7645, 
New England BioLabs®Inc, MA, USA), following the manufacturer’s instructions starting from 10 ng of frag-
mented DNA. After end repair and adaptor ligation, adaptor-ligated DNA clean-up (without size-selection, 
Agencourt AMPure XP magnetic beads, Beckman Coulter Life Sciences, CA, USA), library enrichment 
(98°C × 30 sec; 98°C × 10 secplus 65°C × 75 min × 10 cycles; 65°C × 5 min, in a Bio-Rad thermal cycler, Bio-Rad, 
Richmond, CA, USA), and PCR clean up (Agencourt AMPure XP magnetic beads, Beckman Coulter Life Sciences, 
Figure 4. Analysis of the expression of selected genes involved in CNS development Arghap4: Rho GTP-ase 
activating protein 4; Casp6: Caspase 6; Chmp1a: Charged multi-vesicular body protein 1a; Col4a3: Collagenase 
4 a3; Icam1: Intracellular adhesion molecule 1; Mag: Myelin-associated glycoprotein; Ptk2: Protein tyrosine 
kinase 2 beta; Il6: Interleukin 6. P: post-natal age in days, Adult: more than 1-year-old. White bars: ctrl; Black 
bars: jj. Results are expressed as mean ± S.D. of 6 animals each genotype/age. Unpaired t-test with Welch 
correction, *p < 0.05; **p < 0.05; ***p < 0.005 vs. age-matched controls.
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CA, USA), the libraries were quantified using the PicoGreen fluorescent dye, as reported above, and stored at 
−20 °C. Before sequencing, libraries were denatured and diluted to a final concentration of 15 pM with 10% PhiX 
(Illumina, New England BioLabs®Inc, MA, USA) control. Paired-end sequencing was performed using the MiSeq 
reagent kit v3 2 × 150 in the Illumina® MiSeq® system (Illumina, San Diego, CA, USA). A total of 4 P9 jj Cll (2 
runs) and 3 P9 control Cll (1 run) were used. Reads were mapped to the Rattus norvegicus (rn4) genome using 
bowtie246. Duplicate reads were filtered. The quality of the sequences was evaluated using fastQC (http://www.bio-
informatics.babraham.ac.uk/projects/fastqc/). Peaks were called using MACS247 and annotated using HOMER 
software48. Functional enrichment study was determined using GeneCodis (http://genecodis.cnb.csic.es/, 
hypergeometric test, FDR corrected)16–18.
Histology and morphometric analysis. Immediately after animals sacrifice, the brain was removed from 
the skull and fixed in 4% formalin buffered solution (4% formaldehyde 37%, 33 nM NaH2PO4, 46 mM Na2HPO4), 
then embedded in paraffin. Sagittal sections of the brain (3–5 μm) were obtained by a microtome (Microm-hm 
340 e- BioOptica, Milan, Italy), affixed on the glass slides and dried at 60 °C for 1 hour. Hematoxylin and eosin 
stain (H&E) was performed by a Leica ST5020 Multistainer (Leica Microsystem, Milan, Italy). Cresyl violet 
(Nissl) staining was performed manually on hydrated sections (xylol 3 × 5 min; 100% ethanol 2 × 2 min; 95% 
ethanol 2 × 2 min; 80% ethanol 1 × 2 min; 70% ethanol 1 × 2 min; H2O 2 × 5 min) by incubating the slices for 
1 hr in cresyl violet solution (0.1% cresyl violet powder, 10 drops glacial acetic acid in H2OmQ). After washing 
(twice H2OmQ), differentiation (75% ethanol, 95% ethanol plus 5% chloroform, 3 drops glacial acetic acid) and 
dehydration (100% ethanol 2 × 5 min; xylol 2 × 5 min), slices were mounted (Eukitt 03989, SIGMA Aldrich). 
Pictures were collected by a D-Sight plus image digital microscope & scanner (Menarini Diagnostics, Firenze, 
Italy). Histology was read by 3 independent pathologists, blinded to experimental design.
RTqPCR on selected genes. RTqPCR was performed as previously described26,43. Total RNA extrac-
tion (Eurogold RNA Pure reagent, Euroclone, Milan, Italy) and retro-transcription (1 μg RNA, High Capacity 
cDNA Reverse Transcription Kit, Applied Biosystems, Monza, Italy) were performed following the manufacturer 
instruction in a thermal cycler (Gene Amp PCR System 2400, Perkin-Elmer, Boston, MA, USA) at 25 °C for 
5 min, 37 °C for 120 min, and 85 °C for 5 min. The final cDNA was stored at 20 °C until use. Primers were designed 
using the Beacon designer 8.1 software (Premier Biosoft International, Palo Alto, CA, USA) on rat sequences 
available in GenBank (Table 2). RtqPCR was performed in an iCycler iQ thermocycler (Bio-Rad Laboratories, 
Hercules, CA, USA) in presence of 25 ng of cDNA, sense and antisense gene-specific primers (250 nM each), in 
SSoAdvance SYBER green supermix (Bio-Rad Laboratories, Hercules, CA, USA). Amplification protocol was 
95 °C × 3 min, 40 cycle of 95° C × 20 sec; 60 °C × 20 sec and 72 °C × 30 sec, followed by 72 °C × 5 min. Melting 
curve analysis was performed to assess product specificity. The relative quantification was made using the iCycler 
iQ Software, version 3.1 (Bio-Rad Laboratories, Hercules, CA, USA) by the Pfaffl modification of the ΔΔCT 
equation, taking into account the efficiencies of the individual genes49,50. The results were normalized to the 
housekeeping genes and the levels of mRNA were expressed relative to a reference sample50,51.
Statistics. The statistical analysis was performed by GraphPad InStat for Windows (GraphPad Software, Inc, 
La Jolla, CA, USA). The ANOVA test, followed by Tukey-Kramer multiple comparison tests, was used to analise 
TSB, cBf, and Cll weight during the development. The unpaired two-tailed Student’s t-test, based on unequal 
variance, was applied to evaluate the difference between jj and controls at the same age (Western blot, RTqPCR). 
All data are expressed as mean ± S.D. of multiple biological repetition. A p-value lower than 0.05 was considered 
statistically significant.
Data Availability
ChIP-Seq – full result available on GEO repository # GSE109145.
Gene
Accession 
number Forward Revers Efficiency
Amplicon 
length 
(bp)
Agrn NM_175754 TACCTGTCCACTTGTATT TTCTCATCCAATAACACATT 98.5 87
Arhgap4 NM_144740 CTTGTGAGCCATCTACTATC GTTGAGGAAGGTGAAGAG 88 75
Anxa2 NM_019905 CTACTGTCCACGAAATCCTG AAGTTGGTGTAGGGTTTGAC 99.8 94
Casp6 NM_031775 ACAGATGGCTTCTACAGA AGTTCCTCTCCTCTTGTG 102.2 78
Chmp1a NM_001083313 ATCAACTTACAGGTTAGG TACTTACGACAACATTCTA 98.2 122
Col4a3 NM_001135759 TCACCACAATGCCATTCTTA CGACAGCCAGTATGAATAGT 94.5 83
Icam1 NM_012967 ACCTACATACATTCCTACC ATGAGACTCCATTGTTGA 96.3 91
Mag NM_017190 ACCATCCAACCTTCTGTATC CTGATTCCGCTCCAAGTG 96.2 90
Ptk2b NM_017318 TGTCTACACGAACCATAA GAACTTCTCCTTGTTGTC 93.1 88
Tubb2b NM_001013886 CAGTTGGAAGAAGGAGAA AGTGTTACATTGATGTTATCG 107.5 111
Il6 NM_012589.1 GCCCACCAGGAACGAAAGTC TCCTCTGTGAAGTCTCCTCTCC 107.7 161
Hprt NM_012583.2 AGACTGAAGAGCTACTGTAATGAC GGCTGTACTGCTTGACCAAG 94.9 163
Table 2. Primers specification.
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